Skip to main content
. 2016 Apr 20;7(20):29761–29769. doi: 10.18632/oncotarget.8858

Table 1. Altered mutations/CNVs stratified for therapy administered.

Number of mutations Number of altered mutations Number of CNVs Number of altered CNVs Overall detected Overall altered
RCTX 20 3 (15%) 7 0 (0%) 27 3 (11%)
CTX 48 11 (23%) 26 6 (23%) 74 17 (23%)
Cis/Vino 21 2 (10%) 4 0 (0%) 25 2 (8%)
Cis/Pem 7 4 (57%) 2 2 (100%) 9 6 (67%)
Cis/Tax 14 0 (0%) 9 0 (0%) 23 0 (0%)
Cis/Gem 26 8 (31%) 18 4 (22%) 44 12 (27%)